Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
22 03 2019
Historique:
received: 20 12 2018
revised: 18 01 2019
pubmed: 27 1 2019
medline: 22 1 2020
entrez: 26 1 2019
Statut: ppublish

Résumé

The activation of viral glycoproteins by the host protease furin is an essential step in the replication of numerous pathogenic viruses. Thus, effective inhibitors of furin could serve as broad-spectrum antiviral drugs. A crystal structure of an inhibitory hexapeptide derivative in complex with furin served as template for the rational design of various types of new cyclic inhibitors. Most of the prepared derivatives are relatively potent furin inhibitors with inhibition constants in the low nanomolar or even sub-nanomolar range. For seven derivatives the crystal structures in complex with furin could be determined. In three complexes, electron density was found for the entire inhibitor. In the other cases the structures could be determined only for the P6/P5-P1 segments, which directly interact with furin. The cyclic derivatives together with two non-cyclic reference compounds were tested as inhibitors of the proteolytic activation and replication of respiratory syncytial virus in cells. Significant antiviral activity was found for both linear reference inhibitors, whereas a negligible efficacy was determined for the cyclic derivatives.

Identifiants

pubmed: 30680958
doi: 10.1002/cmdc.201800807
doi:

Substances chimiques

Enzyme Inhibitors 0
Macrocyclic Compounds 0
Proprotein Convertases EC 3.4.21.-
Furin EC 3.4.21.75

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

673-685

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA042351
Pays : United States

Informations de copyright

© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Thuy Van Lam van (T)

Institute of Pharmaceutical Chemistry, Philipps University, Marbacher Weg 6, 35032, Marburg, Germany.

Teodora Ivanova (T)

Institute of Pharmaceutical Chemistry, Philipps University, Marbacher Weg 6, 35032, Marburg, Germany.

Kornelia Hardes (K)

Institute of Pharmaceutical Chemistry, Philipps University, Marbacher Weg 6, 35032, Marburg, Germany.

Miriam Ruth Heindl (MR)

Institute of Virology, Philipps University, Hans-Meerwein-Str. 2, 35043, Marburg, Germany.

Rory E Morty (RE)

Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

Eva Böttcher-Friebertshäuser (E)

Institute of Virology, Philipps University, Hans-Meerwein-Str. 2, 35043, Marburg, Germany.

Iris Lindberg (I)

Department of Anatomy and Neurobiology, University of Maryland Medical School, Baltimore, MD, 21201, USA.

Manuel E Than (ME)

Protein Crystallography Group, Leibniz Institute on Aging-Fritz Lipmann Institute, Beutenbergstr. 11, 07745, Jena, Germany.

Sven O Dahms (SO)

Department of Biosciences, University of Salzburg, Billrothstrasse 11, 5020, Salzburg, Austria.

Torsten Steinmetzer (T)

Institute of Pharmaceutical Chemistry, Philipps University, Marbacher Weg 6, 35032, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH